Thus, the dysregulated/enhanced IL-6 gene expression in neoplastic, stromal, or tumor-adjacent immune cells and IL-6-driven cell proliferation contribute to increased aggressiveness of certain neoplastic diseases. Here, IL6 is linked to neoplasm.